About Neuroptics
Neuroptics is a company based in Irvine (United States) founded in 1995. Neuroptics has raised $1.8 million across 6 funding rounds from investors including HHS. Neuroptics offers products and services including NPi-300 Pupillometer and Applied Research Instrumentation.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuroptics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.8 M (USD)
in 6 rounds
-
Latest Funding Round
$2.68 M (USD), Grant
Jul 01, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuroptics
Neuroptics offers a comprehensive portfolio of products and services, including NPi-300 Pupillometer and Applied Research Instrumentation.
The NPi-300 pupillometer is used for accurate measurement of pupil size and reactivity in critical care settings, providing objective data that supports clinical assessments.
Instrumentation for applied research is offered, including devices for monocular or binocular pupillometry in human and animal studies across various research applications.
People of Neuroptics
Unlock access to complete
Funding Insights of Neuroptics
Neuroptics has successfully raised a total of $1.8M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.68 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neuroptics
Neuroptics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Neuroptics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuroptics
Investment portfolio details for Neuroptics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuroptics
Detailed financials for Neuroptics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuroptics Comparisons
Peer comparison for Neuroptics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuroptics
Detailed competitors of Neuroptics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuroptics
Complete news archive for Neuroptics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuroptics
Neuroptics was founded in 1995 and raised its 1st funding round 16 years after it was founded.
Neuroptics is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Neuroptics is a funded company, having raised a total of $1.8M across 6 funding rounds to date.
Founded in 1995 and based in Irvine, United States, Neuroptics operates in the medical technology sector. Pupillometers are designed and manufactured by the company for objective assessment of pupil size and reactivity. These devices are utilized in critical care, neurology, neurosurgery, and emergency medicine to support clinical decisions. Instrumentation is also provided for monocular or binocular pupillometry in human and animal research, facilitating data collection independent of examiners.
Neuroptics offers NPi-300 Pupillometer and Applied Research Instrumentation.
Neuroptics has 1 investor. Key investors include HHS.